News

Developing approved therapies for ALS has been painfully slow, as evidenced by the failure of more than 95 per cent of ALS ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...
In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...
Long-term exposure to sulfur dioxide, an air pollutant generated by the burning of fossil fuels, increases the risk of ALS, a ...
Tommy and Vickie Smith have faced more than their share of health challenges. Tommy has been living with amyotrophic lateral ...
A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.
In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined saying.
Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...
A brain-computer interface has enabled people with paralysis to turn their thoughts directly into words, requiring less ...
New advances in brain-computer interface (BCI) technology may make speech for those who've lost the ability to do easier than ...
Stone will be joining Dane — whom she has been friends with "for a long time" — on the long-awaited third season of the HBO ...
In May 2025, the DSMB recommended continuation of the trial as planned without any modification and clearance to proceed to the next dosing level, from the 5mg/kg dose of PMN310 in the first cohort to ...